| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |